About Jennifer Ahlstrom
Articles by Jennifer Ahlstrom
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
HealthTree Cure Tour: Syracuse with Drs. Malek and GhimireApr 19, 2024
Positive Vote by FDA ODAC Committee to use MRD as Earlier Myeloma Clinical Trial EndpointApr 15, 2024
Register for the Charlotte HealthTree for Myeloma RoundTable on May 4thApr 10, 2024
Two Myeloma CAR T Therapies Receive FDA Approval for Earlier UseApr 09, 2024
Register for the Miami HealthTree for Myeloma RoundTable on April 20thApr 03, 2024
IBC 2024: Longer Life with Myeloma Uncovers New Blood DisorderMar 28, 2024
CAR T Therapy Gets First European Approval in Earlier Lines for Multiple MyelomaMar 21, 2024
¿Cuáles Son las Causas del Mieloma Múltiple? ¿Y Qué se Puede Hacer al Respecto?Mar 20, 2024
What We Know About the Myeloma Translocation 11;14Mar 17, 2024
Uso de Antioxidantes Para Mejorar la Función de las Células T en el MielomaMar 13, 2024
How Should We Run Clinical Trials in Myeloma? A Meeting Between Myeloma Experts, Industry and FDAMar 11, 2024
Es Descubierto un Potencial Objetivo Para el Tratamiento del Mieloma MúltipleFeb 26, 2024
ASH 2023: Clinical Investigator Perspectives on the Management of Patients with Multiple MyelomaJan 30, 2024
White Bean ChiliJan 22, 2024
Who Holds the Key to a Myeloma Cure? A Thank You to Our Community.Jan 04, 2024
ASH 2023: How Your Insurance Type May Affect Your Blood Cancer OutcomeJan 02, 2024
Ensayo Clínico: Probando un Nuevo Sistema de Administración en el Organismo de Isatuximab en el Mieloma MúltipleDec 26, 2023
It's Time for Myeloma CuresDec 18, 2023
¿Qué es la Neuropatía Periférica?Dec 18, 2023